These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
382 related articles for article (PubMed ID: 22240504)
1. Relationships of HLA-B51 or B5 genotype with Behcet's disease clinical characteristics: systematic review and meta-analyses of observational studies. Maldini C; Lavalley MP; Cheminant M; de Menthon M; Mahr A Rheumatology (Oxford); 2012 May; 51(5):887-900. PubMed ID: 22240504 [TBL] [Abstract][Full Text] [Related]
2. HLA-B51/B5 and the risk of Behçet's disease: a systematic review and meta-analysis of case-control genetic association studies. de Menthon M; Lavalley MP; Maldini C; Guillevin L; Mahr A Arthritis Rheum; 2009 Oct; 61(10):1287-96. PubMed ID: 19790126 [TBL] [Abstract][Full Text] [Related]
3. Contribution of Hla-B51 in the susceptibility and specific clinical features of Behcet's disease in Tunisian patients. Hamzaoui A; Houman MH; Massouadia M; Ben Salem T; Khanfir MS; Ben Ghorbel I; Miled M Eur J Intern Med; 2012 Jun; 23(4):347-9. PubMed ID: 22560383 [TBL] [Abstract][Full Text] [Related]
4. Allelic distribution of HLA-B*5 in HLA-B5-positive Israeli patients with Behçet's disease. Paul M; Klein T; Krause I; Molad Y; Narinsky R; Weinberger A Tissue Antigens; 2001 Sep; 58(3):185-6. PubMed ID: 11703827 [TBL] [Abstract][Full Text] [Related]
5. HLA-B*5101 in Greek patients with Behçet's disease. Koumantaki Y; Stavropoulos C; Spyropoulou M; Messini H; Papademetropoulos M; Giziaki E; Marcomichelakis N; Palimeris G; Kaklamanis P; Kaklamani E Hum Immunol; 1998 Apr; 59(4):250-5. PubMed ID: 9568801 [TBL] [Abstract][Full Text] [Related]
6. Dose HLA-B5, 7, 8, 27, and 51 Antigens Associated to Behcet's disease? A Study in Southwestern Iran. Rajaei E; Jalali MT; Pezeshki SMS; Rezaeeyan H; Maniati M; Elyasi M; Zayeri ZD Curr Rheumatol Rev; 2020; 16(2):120-124. PubMed ID: 31533601 [TBL] [Abstract][Full Text] [Related]
7. HLA-B51 Impact on Clinical Symptoms in Behcet's Disease. Pamukcu M; Duran TI; Demirag MD J Coll Physicians Surg Pak; 2022 Jul; 32(7):904-908. PubMed ID: 35795941 [TBL] [Abstract][Full Text] [Related]
8. HLA-B51 and its allelic types in association with Behçet's disease and recurrent aphthous stomatitis in Korea. Chang HK; Kim JU; Cheon KS; Chung HR; Lee KW; Lee IH Clin Exp Rheumatol; 2001; 19(5 Suppl 24):S31-5. PubMed ID: 11760395 [TBL] [Abstract][Full Text] [Related]
9. A strong association between HLA-B*5101 and Behçet's disease in Greek patients. Mizuki N; Ohno S; Ando H; Chen L; Palimeris GD; Stavropoulos-Ghiokas E; Ishihara M; Goto K; Nakamura S; Shindo Y; Isobe K; Ito N; Inoko H Tissue Antigens; 1997 Jul; 50(1):57-60. PubMed ID: 9243757 [TBL] [Abstract][Full Text] [Related]
10. Association of HLA-B51 subtypes and Behçet's disease in Spain. González-Escribano MF; Rodríguez MR; Walter K; Sanchez-Roman J; García-Lozano JR; Núñez-Roldán A Tissue Antigens; 1998 Jul; 52(1):78-80. PubMed ID: 9714478 [TBL] [Abstract][Full Text] [Related]
11. Close association of HLA-B51 and B52 in Israeli patients with Behçet's syndrome. Arber N; Klein T; Meiner Z; Pras E; Weinberger A Ann Rheum Dis; 1991 Jun; 50(6):351-3. PubMed ID: 2059078 [TBL] [Abstract][Full Text] [Related]
12. HLA-B51 subtypes in Turkish patients with Behçet's disease and their correlation with clinical manifestations. Demirseren DD; Ceylan GG; Akoglu G; Emre S; Erten S; Arman A; Metin A Genet Mol Res; 2014 Jul; 13(3):4788-96. PubMed ID: 25062414 [TBL] [Abstract][Full Text] [Related]
13. Behçet's disease in Tunisia. Demographic, clinical and genetic aspects in 260 patients. Houman MH; Neffati H; Braham A; Harzallah O; Khanfir M; Miled M; Hamzaoui K Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S58-64. PubMed ID: 17949553 [TBL] [Abstract][Full Text] [Related]
14. Adamantiades-Behçet Disease at the Beginning of the Silk Route: North-East Italian Experience. Bergamo S; di Meo N; Stinco G; Bonin S; Trevisini S; Trevisan G Acta Dermatovenerol Croat; 2017 Dec; 25(4):295-297. PubMed ID: 30064603 [TBL] [Abstract][Full Text] [Related]
15. Association of MICA polymorphism with HLA-B51 and disease severity in Korean patients with Behcet's disease. Park SH; Park KS; Seo YI; Min DJ; Kim WU; Kim TG; Cho CS; Mok JW; Park KS; Kim HY J Korean Med Sci; 2002 Jun; 17(3):366-70. PubMed ID: 12068141 [TBL] [Abstract][Full Text] [Related]
16. The influence of HLA-B51 on clinical manifestations among Japanese patients with Behçet's disease: A nationwide survey. Mizuki Y; Horita N; Horie Y; Takeuchi M; Ishido T; Mizuki R; Kawagoe T; Shibuya E; Yuda K; Ishido M; Minegishi K; Yoshimi R; Kirino Y; Kato S; Arimoto J; Fukumoto T; Kurosawa M; Kitaichi N; Takeno M; Kaneko T; Mizuki N Mod Rheumatol; 2020 Jul; 30(4):708-714. PubMed ID: 31386589 [No Abstract] [Full Text] [Related]
17. Primary association of HLA-B51 with Behçet's disease in Ireland. Kilmartin DJ; Finch A; Acheson RW Br J Ophthalmol; 1997 Aug; 81(8):649-53. PubMed ID: 9349151 [TBL] [Abstract][Full Text] [Related]
19. Lack of association of HLA-B*51 with a severe disease course in Behçet's disease. Gül A; Uyar FA; Inanc M; Ocal L; Tugal-Tutkun I; Aral O; Koniçe M; Saruhan-Direskeneli G Rheumatology (Oxford); 2001 Jun; 40(6):668-72. PubMed ID: 11426025 [TBL] [Abstract][Full Text] [Related]
20. Gender-specific differences in Adamantiades-Behçet's disease manifestations: an analysis of the German registry and meta-analysis of data from the literature. Bonitsis NG; Luong Nguyen LB; LaValley MP; Papoutsis N; Altenburg A; Kötter I; Micheli C; Maldini C; Mahr A; Zouboulis CC Rheumatology (Oxford); 2015 Jan; 54(1):121-33. PubMed ID: 25118314 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]